A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia …

T Kühr, S Burgstaller, U Apfelbeck, W Linkesch… - Leukemia Research, 2003 - Elsevier
This multicenter randomized phase III study was designed to compare the efficacy and
toxicity of IFNα-2c (3.5 MU/d) in combination with either araC (10mg/m2 d1-10) or …
被引用次数：42 相关文章

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia …

T Kühr, S Burgstaller, U Apfelbeck, W Linkesch… - Leukemia …, 2003 - europepmc.org
This multicenter randomized phase III study was designed to compare the efficacy and
toxicity of IFN alpha-2c (3.5 MU/d) in combination with either araC (10 mg/m (2) d1-10) or …

[引用][C] A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid …

T KÜHR, S BURGSTALLER, J PONT… - Leukemia …, 2003 - pascal-francis.inist.fr
Author KÜHR, T 1; BURGSTALLER, S 1; PONT, J 8; KÖCK, L 9; ABBREDERIS, K 10;
BALDINGER, C 1; BUDER, R 11; GEISSLER, D 12; HAUSMANINGER, H 13; LANG, A 14; …
[PDF] academia.edu

[PDF][PDF] A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid …

T Kühr, S Burgstaller, U Apfelbeck, W Linkesch… - Leukemia …, 2003 - academia.edu
This multicenter randomized phase III study was designed to compare the efficacy and
toxicity of IFNα-2c (3.5 MU/d) in combination with either araC (10 mg/m2 d1-10) or …

[引用][C] A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid …

T Kühr, S Burgstaller, U Apfelbeck… - LEUKEMIA …, 2003 - pure.pmu.ac.at
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon
plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML). — PMU …

A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia …

T Kühr, S Burgstaller, U Apfelbeck… - Leukemia …, 2003 - pubmed.ncbi.nlm.nih.gov
This multicenter randomized phase III study was designed to compare the efficacy and
toxicity of IFN alpha-2c (3.5 MU/d) in combination with either araC (10 mg/m (2) d1-10) or …

A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia …

T Kühr, S Burgstaller, U Apfelbeck, W Linkesch… - Leukemia Research, 2003 - infona.pl
This multicenter randomized phase III study was designed to compare the efficacy and
toxicity of IFNα-2c (3.5 MU/d) in combination with either araC (10mg/m 2 d1-10) or …

A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia …

T Kuhr, S Burgstaller, U Apfelbeck, W Linkesch… - Leukemia …, 2003 - elibrary.ru
This multicenter randomized phase III study was designed to compare the efficacy and
toxicity of IFNα-2c (3.5 MU/d) in combination with either araC (10mg/m 2 d1-10) or …

[引用][C] A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid …

T Kühr, S Burgstaller, U Apfelbeck… - LEUKEMIA …, 2003 - pure.pmu.ac.at
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and
interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML) …

[引用][C] A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid …

T KÜHR, S BURGSTALLER, U APFELBECK… - Leukemia research, 2003 - Elsevier